Gerald I. Shulman

from Wikipedia, the free encyclopedia

Gerald I. Shulman (* 1953 ) is an American diabetologist and metabolic physiologist at Yale University .

Shulman earned a bachelor's degree in biophysics from the University of Michigan in 1974 and a Ph.D. from Wayne State University in 1979. in physiology as well as an MD (professional doctorate) as a medical degree. As an intern, he worked at Duke University Hospital before joining Harvard Medical School and Massachusetts General Hospital as a research assistant in 1981 . In 1982 he became a specialist in internal medicine . As a postdoctoral fellow, he worked in biochemistry and biophysics at Yale University in 1983/84 .

In 1984/85 Shulman was a lecturer (instructor) at Harvard Medical School before he received his first professorship (assistant professor) in internal medicine and became a specialist in endocrinology and metabolism . In 1987 he moved back to Yale University as an assistant professor , in 1989 he became an associate professor and in 1996 he was given a full professorship. Since 1997 Shulman has also been doing research for the Howard Hughes Medical Institute (HHMI). He has been the George R. Cowgill Professor of Biochemistry since 2008 and has been co-director of the Diabetes Research Center at Yale University since 2012 . As a doctor, he works at Yale New Haven Hospital , Yale University's premier teaching hospital.

Gerald I. Shulman used magnetic resonance spectroscopy to conduct non-invasive research into the intracellular metabolism of glucose and fatty acids , which enabled him to contribute significantly to the understanding of the pathophysiology of insulin resistance and type 2 diabetes mellitus . He showed the importance of gluconeogenesis in the liver for diabetes and the development of fatty liver and that even a slight weight reduction leads to considerable improvements in metabolism. Further work dealt with the insulin- dependent lipid metabolism in muscle cells and how it can be influenced by exercise and pharmaceuticals, with which new drug therapy approaches for diabetes could be developed.

Shulman is the author of more than 500 scientific publications . According to Google Scholar (as of October 2019), it has an h-index of 163, according to the Scopus database of 141.

Awards (selection)

Web links

Individual evidence

  1. Gerald I Shulman. In: scholar.google.de. Google Scholar , accessed October 14, 2019 .
  2. Shulman, Gerald I. In: scopus.com. Scopus , accessed October 14, 2019 .
  3. Gerald I. Shulman, MD, PhD at the American Society for Clinical Investigation (the-asci.org); accessed on May 2, 2018.
  4. Gerald Shulman. In: nasonline.org. Retrieved May 2, 2018 .
  5. ^ The 2008 Stanley J. Korsmeyer Award: Gerald I. Shulman, MD, PhD. In: the-asci.org. Retrieved May 2, 2018 .
  6. ^ Karen Honey: Gerald Shulman digests his award . In: Journal of Clinical Investigation . tape 118 , no. 4 , April 1, 2008, p. 1212 , doi : 10.1172 / JCI35507 .
  7. Shulman, Gerald. In: aaas.org. February 24, 2017, accessed May 2, 2018 .
  8. Book of Members 1780 – present, Chapter S. (PDF; 1.4 MB) In: American Academy of Arts and Sciences (amacad.org). Accessed October 7, 2018 (English).
  9. ^ American Diabetes Association: American Diabetes Association Announces Eight Recipients of 2018 National Scientific and Health Care Achievement Awards. In: prnewswire.com. April 27, 2018, accessed May 2, 2018 .